University Heart & Vascular Center Hamburg, Department of Cardiology; Institute of Cardiovascular Sciences, University of Birmingham, UK.
Dtsch Arztebl Int. 2023 Aug 21;120(33-34):564-574. doi: 10.3238/arztebl.m2023.0052.
Perioperative arrhythmias are common depending on the type of the operation and can increase morbidity and mortality.
This review is based on pertinent publications retrieved by a selective search in PubMed, as well as the relevant European guidelines.
Arrhythmias are seen in more than 90% of cardiac operations; they are usually transient and often asymptomatic. The risk factors for arrhythmia include ion channel diseases, old age, structural heart disease, cardiac surgery, noncardiac surgery with major fluid shifts, and pulmonary resection. The full spectrum of supraventricular and ventricular arrhythmias can arise perioperatively. Correct ECG interpretation, consideration of the arrhythmia in the overall clinical context, and an understanding of its causes, pathophysiology, and options for effective treatment are critically important. According to a meta-analysis, betablockers lower the risk of perioperative atrial fibrillation (OR = 0.56; 95% confidence interval: [0.35; 0.91]). If anticoagulant treatment is not interrupted for surgery, there is less bleeding with direct oral anticoagulants than with vitamin K antagonists (relative risk: 0.62 [0.47; 0.82]). Moreover, clinical follow-up is important, especially for patients with new-onset atrial fibrillation or heart failure.
The identification of high-risk patients and the provision of individualized perioperative monitoring are essential aspects of patient safety. Outpatient cardiological follow-up can improve outcomes.
围手术期心律失常较为常见,取决于手术类型,并可能增加发病率和死亡率。
本综述基于在 PubMed 中进行的选择性搜索以及相关欧洲指南中检索到的相关出版物。
心律失常可见于 90%以上的心脏手术中;它们通常是短暂的,并且常常无症状。心律失常的危险因素包括离子通道疾病、高龄、结构性心脏病、心脏手术、伴有大量液体转移的非心脏手术以及肺切除术。围手术期可能会出现各种室上性和室性心律失常。正确解读心电图、考虑心律失常在整体临床背景下的情况以及了解其病因、病理生理学和有效治疗方案至关重要。一项荟萃分析显示,β受体阻滞剂降低了围手术期心房颤动的风险(OR=0.56;95%置信区间:[0.35;0.91])。如果手术期间不中断抗凝治疗,直接口服抗凝剂的出血风险低于维生素 K 拮抗剂(相对风险:0.62 [0.47;0.82])。此外,临床随访很重要,特别是对于新发心房颤动或心力衰竭的患者。
识别高危患者并提供个体化围手术期监测是患者安全的重要方面。门诊心脏随访可以改善预后。